AbbVie | Resultat Før Skatt



Pre Tax Profit Endring Dato
AbbVie USD 4.81B 1.54B 2024-12
Abbott USD 2.03B 90M 2024-12
ALKERMES USD 443.75M 333.52M 2024-12
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 1.67B 162M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Eisai JPY 29.55B 13.99B 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 563M 2.08B 2024-12
J&J USD 5.42B 1.86B 2024-12
Medtronic USD 1.54B 455M 2025-01
Merck USD 5.22B 114M 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Pacira USD 49.58M 8.89M 2024-09
Perrigo USD 151.3M 11.9M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.18B 1.33B 2024-12
UCB EUR 123M 464.07M 2024-06
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 396.5M 7.9M 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Zoetis USD 773M 144M 2024-12



AbbVie Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.